Elsevier Inc.

SHERPA: Unknown

People

  1. Aghajanian
    Aghajanian
  2. Konner
    Konner
  3. Chi
    Chi
  4. Tew
    Tew
  5. Sabbatini
    Sabbatini
  6. Hensley
    Hensley
  7. Zivanovic
    Zivanovic
  8. Broach
    Broach
  9. Gardner
    Gardner
  10. Grisham
    Grisham

Groups

  1. Department of Medicine (6)
  2. GDMT, Medicine (6)
  3. Gynecologic Medicine Service (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. Surgery (6)
  7. GDMT, Surgery (5)
  8. Epidemiology and Biostatistics (2)
  9. Survivorship Research (2)
  10. Biostatistics Service (1)
Search Within
  1. "Carol Aghajanian"
  2. "Jason Konner"
  3. "Meeting abstract"
Formats
  1. Meeting Abstract (6)
Groups
  1. Department of Medicine (6)
  2. GDMT, Medicine (6)
  3. Gynecologic Medicine Service (6)
  4. Gynecology Disease Management Team (6)
  5. Solid Tumor Oncology Division (6)
  6. Surgery (6)

More Groups

People
  1. Carol Aghajanian (6)
  2. Jason Konner (6)
  3. Dennis Chi (5)
  4. William Tew (5)
  5. Paul Sabbatini (4)
  6. Richard Barakat (4)

More People

Years
  1. 2020 (1)
  2. 2014 (1)
  3. 2012 (1)
  4. 2010 (1)
  5. 2009 (1)
  6. 2007 (1)
Publications
  1. Gynecologic Oncology (6)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Optimizing number of preoperative neoadjuvant chemotherapy cycles and survival in newly diagnosed ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Chi, D. S.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; Konner, J.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Risk of developing uterine corpus cancer (Ut Ca) following risk-reducing salpingo-oophorectomy (RRSO) in women with BRCA mutations
    Meeting Abstract

    Shu, C. A.; Pike, M.; Jotwani, A. R.; Soslow, R. A.; Levine, D. A.; Konner, J.; Aghajanian, C.; Offit, K.; Barakat, R. R.; Kauff, N. D.
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save
  • Progression-free and overall survival of a modified outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin is comparable to results from GOG 172
    Meeting Abstract

    Barlin, J.; Dao, F.; Zgheib, N. B.; Ferguson, S.; Sabbatini, P.; Hensley, M.; Konner, J.; Tew, W.; Aghajanian, C.; Chi, D.
    Gynecologic Oncology (2012)

    Fulltext@MSK | Save
  • Analysis of progression-free survival, tolerability and toxicity in patients with stage III ovarian, tubal and peritoneal carcinoma treated with an outpatient regimen of primary intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin
    Meeting Abstract

    Chi, D.; Dao, F.; Ferguson, S.; Sabbatini, P.; Hensley, M.; Konner, J.; Tew, W.; Bell-Mcguinn, K.; Barakat, R.; Aghajanian, C.
    Gynecologic Oncology (2010)

    Fulltext@MSK | Save
  • Incidence and management of bevacizumab-associated gastrointestinal perforation in patients with recurrent ovarian carcinoma
    Meeting Abstract

    Diaz, J. P.; Zivanovic, O.; Tew, W. P.; Konner, J.; Sabbatini, P. J.; Chi, D. S.; Aghajanian, C.; Barakat, R. R.
    Gynecologic Oncology (2009)

    Fulltext@MSK | Save
  • Toxicity of a modified outpatient regimen of intravenous/intraperitoneal paclitaxel and intraperitoneal cisplatin in women with newly diagnosed ovarian cancer
    Meeting Abstract

    Ferguson, S. E.; Black, D.; Chi, D. S.; Sabbatini, P.; Konner, J.; Tew, W. P.; Hensley, M. L.; Barakat, R. R.; Aghajanian, C.
    Gynecologic Oncology (2007)

    Fulltext@MSK | Save